Sales 2024 * | 2.8B 3.03B | Sales 2025 * | 2.77B 3B | Capitalization | 21.55B 23.38B |
---|---|---|---|---|---|
Net income 2024 * | -435M -472M | Net income 2025 * | -508M -551M | EV / Sales 2024 * | 2.42 x |
Net cash position 2024 * | 14.78B 16.02B | Net cash position 2025 * | 13.76B 14.92B | EV / Sales 2025 * | 2.82 x |
P/E ratio 2024 * |
-49.5
x | P/E ratio 2025 * |
-44.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.48% |
Latest transcript on BioNTech SE
Managers | Title | Age | Since |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 08-06-01 |
Özlem Türeci
FOU | Founder | 57 | 08-06-01 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 69 | 21-12-31 |
Director/Board Member | 67 | 08-06-01 | |
Helmut Jeggle
CHM | Chairman | 53 | 08-06-01 |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 118B | |
+12.15% | 106B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B | |
-2.52% | 7.53B |